MedTrace Logo

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

NCT00415376 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-05-18

No results posted yet for this study

Summary

RATIONALE: Anticonvulsant drugs, such as levetiracetam, may help control seizures caused by brain metastases.

PURPOSE: This clinical trial is studying the side effects and how well levetiracetam works in treating patients with seizures caused by brain metastases.

Conditions

Interventions

DRUG

levetiracetam

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

Principal Investigators

  • Jeffrey J. Raizer, MD · Robert H. Lurie Cancer Center

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-07-31
Completion
2007-07-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415376 on ClinicalTrials.gov